GE HealthCare (NYSE:GEHC) has unveiled Carestation 850, its next-generation anesthesia delivery system.
The FDA 510(k)-pending system aims to help care teams adapt to evolving clinical and operational needs. It could potentially advance anesthesia care through tools, customizable applications and a sleek, space-conscious footprint.
Chicago-based GE HealthCare’s FDA submission follows recent CE mark in Europe and approval in Australia and New Zealand.
Dr. John Beard, an anesthesiologist, serves as chief medical officer for Patient Care Solutions at GE HealthCare. Beard said in a news release that the new system can help ease burdens and support safer, more effective care delivery.
“We’re excited about the potential of Carestation 850 to meet today’s demands in anesthesia delivery and evolve with health systems in the future,” said Beard.
GE HealthCare designed Carestation 850 to help clinicians more confidently care for each patient and optimize procedural outcomes. It features an intuitive widescreen display and enhanced user interface to deliver clear data visualization and support clinical decision-making.
The system also features a vaporization platform designed with advanced alerting capabilities. It has the ability to refill while in use to help anesthesia providers proactively manage cases and minimize disruptions. GE HealthCare also said it included tools and applications to aid health systems’ sustainability goals.
“The unveiling of Carestation 850 reinforces our commitment to advancing care that can think one step ahead with its potential to evolve with the changing health systems’ needs through continuously optimized algorithms and adaptable technologies,” said Alla K. Woodson, GM, Anesthesia and Global Services, GE HealthCare. “We listened to our customers, and with their help we created Carestation 850, a solution that has potential to transform the future of perioperative care and complement the expertise of clinicians in the operating room by delivering precision, sustainability and efficiency.”
